HIGHLIGHTS
- who: Siyi Zou from the Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, No197, Rui Jin Er Road, Shanghai, China have published the paper: Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: a retrospective cohort study, in the Journal: (JOURNAL)
- what: The authors aimed to propose the concept of postoperative hyperprogression disease (PO-HPD) for PDAC to clarify recurrence within 2 months after curable-intent resection, explore the role of surgery for postoperative HPD patients, and determine the predictive factors based on preoperative clinicophysiological . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.